Loading...
Discoidin Domain Receptor 1 functionally interacts with the IGF-I system in bladder cancer
Buraschi, Simone ; Morcavallo, Alaide ; Neill, Thomas ; Stefanello, Manuela ; Palladino, Chiara ; Xi, Shi-Qiong ; Belfiore, Antonino ; Iozzo, Renato V. ;
Buraschi, Simone
Morcavallo, Alaide
Neill, Thomas
Stefanello, Manuela
Palladino, Chiara
Xi, Shi-Qiong
Belfiore, Antonino
Iozzo, Renato V.
Citations
Altmetric:
Genre
Journal article
Date
2020-01-07
Advisor
Committee member
Group
Department
Biology
Subject
Permanent link to this record
Collections
Research Projects
Organizational Units
Journal Issue
DOI
https://doi.org/10.1016/j.mbplus.2020.100022
Abstract
Bladder cancer is one of the most common and aggressive cancers and, regardless of the treatment, often recurs and metastasizes. Thus, a better understanding of the mechanisms regulating urothelial tumorigenesis is critical for the design and implementation of rational therapeutic strategies. We previously discovered that the IGF-IR axis is critical for bladder cancer cell motility and invasion, suggesting a possible role in bladder cancer progression. However, IGF-IR depletion in metastatic bladder cancer cells only partially inhibited anchorage-independent growth. Significantly, metastatic bladder cancer cells have decreased IGF-IR levels but overexpressed the insulin receptor isoform A (IR-A), suggesting that the latter may play a more prevalent role than the IGF-IR in bladder tumor progression. The collagen receptor DDR1 cross-talks with both the IGF-IR and IR in breast cancer, and previous data suggest a role of DDR1 in bladder cancer. Here, we show that DDR1 is expressed in invasive and metastatic, but not in papillary, non-invasive bladder cancer cells. DDR1 is phosphorylated upon stimulation with IGF-I, IGF-II, and insulin, co-precipitates with the IGF-IR, and the IR-A and transient DDR1 depletion severely inhibits IGF-I-induced motility. We further demonstrate that DDR1 interacts with Pyk2 and non-muscle myosin IIA in ligands-dependent fashion, suggesting that it may link the IGF-IR and IR-A to the regulation of F-actin cytoskeleton dynamics. Similarly to the IGF-IR, DDR1 is upregulated in bladder cancer tissues compared to healthy tissue controls. Thus, our findings provide the first characterization of the molecular cross-talk between DDR1 and the IGF-I system and could lead to the identification of novel targets for therapeutic intervention in bladder cancer. Moreover, the expression profiles of IGF-IR, IR-A, DDR1, and downstream effectors could serve as a novel biomarker signature with diagnostic and prognostic significance.
Description
Citation
Simone Buraschi, Alaide Morcavallo, Thomas Neill, Manuela Stefanello, Chiara Palladino, Shi-Qiong Xu, Antonino Belfiore, Renato V. Iozzo, Andrea Morrione, Discoidin Domain Receptor 1 functionally interacts with the IGF-I system in bladder cancer, Matrix Biology Plus, Volumes 6–7, 2020, 100022, ISSN 2590-0285, https://doi.org/10.1016/j.mbplus.2020.100022.
Citation to related work
Elsevier
Has part
Matrix Biology, Vol. 6-7
ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu